Ropes & Gray’s M&A attorneys achieved a top six ranking in The Deal’s M&A Power Rankings in the second quarter fueled by its work on a series of large and significant transactions. The firm’s stellar transactional accomplishments were further punctuated by the work of its private equity team which secured a top three ranking from The Deal.
Our M&A attorneys counseled Gilead Sciences Inc. in its exclusive option to acquire Tizona Therapeutics in a deal valued up to $1.5 billion as well as its exclusive option to acquire Pionyr Immunotherapeutics in a transactions valued as high as $1.74 billion. A team guided Novavax in its acquisition of Praha Vaccines, a deal that will be instrumental to the company’s anticipated production of a COVID-19 vaccine. Additionally, Ropes & Gray’s represented Advent International in its initial and renegotiated agreement to acquire Forescout Technologies.
The firm’s approximately 200 M&A and private equity attorneys advised on more than 280 transactions over the past 18 months for an aggregate total of more than $170 billion demonstrating the skills and attention to client needs that are the hallmark of Ropes & Gray.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.